Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J’s Consumer Woes Finally Subside As Pharma Continues Strong

This article was originally published in The Pink Sheet Daily

Executive Summary

The multinational health care company reported significant growth in 2013 that largely was driven by its pharmaceutical division, but bolstered by the resurrection of its long-plagued consumer brands.

You may also be interested in...



Emerging Markets Earnings Roundup: Johnson & Johnson, Abbott (Part 1)

Emerging markets received a lot of attention during the fourth quarter earnings calls of both Abbott Laboratories and J&J. CEOs at both companies proved upbeat on the year ahead and talked about momentum across product lines from medical devices to pharmaceuticals.

Emerging Markets Earnings Roundup: Johnson & Johnson, Abbott (Part 1)

Emerging markets received a lot of attention during the fourth quarter earnings calls of both Abbott Laboratories and J&J. CEOs at both companies proved upbeat on the year ahead and talked about momentum across product lines from medical devices to pharmaceuticals.

J&J’s Solid Launches Lead Strong Pharma Segment Quarter

Johnson & Johnson’s pharma unit posted strong sales growth in immunology and infectious disease, while its burgeoning oncology business is growing substantially.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT142639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel